????? ????? ??????? ?????????? ?? ?????? ?? ?????????? ?? ????? ????? ????? ?? ???????
Phase 2
- Conditions
- Premature ejaculation.F52.4
- Registration Number
- IRCT20180512039618N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 110
Inclusion Criteria
Occurrence of intravaginal ejaculatory latency time less than one minute
Not receiving other treatments in the past month
Male
Single sexual partner
Patient consent for the measurement of ejaculation time
No allergy to paroxetine and dapoxetine and other contraindications
Age 19-65
Exclusion Criteria
No precocious (premature) ejaculation
Azospermia
Men without external genitalia
Occurrence of cryptorchidism in men
Erection inability
Homosexual men
Use of Viagra
Men questioning their gender identity
Men having extramarital sex
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improve Intravaginal Ejaculatory Latency Time up 1.5 min. Timepoint: Paroxetine: daily for 1 mouth , Dapoxetine: before sex activity. Method of measurement: stop watch.
- Secondary Outcome Measures
Name Time Method Travaginal Ejaculatory Latency Time. Timepoint: 1 month. Method of measurement: question.